Arbutus Biopharma and Genevant Sciences are broadening the scope of their patent infringement claims against Moderna with five new international lawsuits. It’s the latest development in a bitter ...

Roivant Sciences (Nasdaq: ROIV) portfolio company Genevant Sciences and Canada’s Arbutus Biopharma (Nasdaq: ABUS) yesterday filed five international lawsuits seeking to enforce patents protecting ...

March 03, 2025 (GLOBE NEWSWIRE) -- Genevant Sciences, a leading nucleic acid delivery company with world-class platforms and a robust lipid nanoparticle (LNP) patent portfolio (a subsidiary of Roivant ...

Genevant and Arbutus are seeking monetary relief and injunctions against Spikevax ® and, where applicable, additional Moderna products that Moderna has represented use the same LNP technology ...

All seven members of Arbutus Biopharma's board have resigned and been replaced by five new members, including the company's new chief executive. The virology-focused biotech company said Tuesday ...

Feb. 25, 2025 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company focused on infectious disease ...

The beloved bakery has shared on Instagram that its Arbutus location will be closing for good on February 17 due to the redevelopment of the building. The team broke the news with heavy hearts ...

Get the latest news on Arbutus Biopharma stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Arbutus Biopharma performance ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

*Estimated payments are calculated by Cars.com and are for informational purposes only. We’ve estimated your taxes based on your provided ZIP code. These estimates do not include title ...